A sixteen-year-old boy with no medical history, no family history of epilepsy, and nothing more sinister than a five-day run of cold-like symptoms, fever, and visual hallucinations became the center of one of the most stubborn neurological emergencies in medicine. Within hours of arriving at hospital, he slipped into generalized convulsive status epilepticus, a state of continuous seizure activity that forced clinicians to intubate him and place him on mechanical ventilation. What followed was more than two weeks of seizures that refused to yield to escalating anesthetic drugs, a month in intensive care, and a ninety-eight-day hospital admission that ended not in death or severe disability, as prognostic models predicted, but in a young man walking independently, eating normally, and speaking close to his premorbid baseline. The case, published as an open-access report in Clinical Case Reports, is a striking reminder that even the grimmest neurological statistics are not destiny.
The condition the teenager developed is known as super-refractory status epilepticus, defined as seizure activity that persists for more than twenty-four hours despite anesthetic therapy, or that returns whenever anesthetics are withdrawn. It is rare but devastating: roughly four to thirteen percent of patients with status epilepticus progress to this super-refractory stage, and long-term mortality ranges from thirty to fifty percent. Of those who survive, only about thirty-five percent are estimated to return to their baseline function, and among survivors discharged from hospital, nearly three-quarters carry moderate to severe disability on the modified Rankin Scale, the standard measure of functional outcome after neurological injury. Median intensive care stays for these patients run between sixteen and a half and thirty-seven days, with correspondingly high costs and high discharge mortality. Against that backdrop, the outcome in this case stands out sharply.
The clinical picture on arrival was confusing. The boy presented with a reduced Glasgow Coma Scale score of twelve after days of fever, periorbital swelling, lethargy, photophobia, and hallucinations. Laboratory tests showed striking liver enzyme elevation, with aspartate aminotransferase at 308 units per liter and alanine aminotransferase at 275, alongside a markedly raised erythrocyte sedimentation rate of 87 millimeters per hour, while C-reactive protein remained normal. Autoimmune screening produced only ambiguous, weakly positive antineutrophil cytoplasmic antibody results judged clinically insignificant. Crucially, the specific antibody panel used to diagnose autoimmune encephalitis was simply unavailable at the treating institution, and in-hospital electroencephalography services did not exist. Diagnosis was further delayed because consent for lumbar puncture came late; cerebrospinal fluid was not obtained until day twelve, and polymerase chain reaction testing found no infectious pathogen.
Treatment began empirically and aggressively. Suspecting encephalitis, clinicians gave intravenous ceftriaxone and acyclovir. On day one, a one-gram loading dose of phenytoin failed to stop the seizures, and anesthetic infusions of propofol, titrated up to 60 micrograms per kilogram per minute, and midazolam were started, supported by noradrenaline for blood pressure. Without continuous EEG, the team could only guess at burst suppression, guiding treatment by visible twitching and convulsions. Sodium valproate was added on day two, then phenobarbital and levetiracetam on day five, with limited effect. The patient received roughly fifteen days of combined propofol and midazolam, and repeated weaning attempts over two weeks triggered recurrent seizures each time, forcing re-escalation. Ketamine at 2 milligrams per kilogram per hour, magnesium sulfate targeting serum levels of 3.5 to 5.0 millimoles per liter, a ketogenic diet from day thirteen, and later lacosamide were all layered on, yet the seizures persisted.
With infection excluded and the clinical syndrome pointing toward autoimmune encephalitis, a potentially reversible cause, the team escalated to empirical immunotherapy on day thirteen: one gram of intravenous methylprednisolone daily for three days, followed by five days of intravenous immunoglobulin at 0.4 grams per kilogram per day. Even this barely dented the seizure activity. Magnetic resonance imaging, delayed until day twenty because of clinical instability, finally supplied the decisive clue. It revealed diffuse bilateral patchy cortical and subcortical T2/FLAIR hyperintense signal abnormalities concentrated in the temporal lobes and thalami, with mild diffusion restriction and no significant contrast enhancement, a pattern considered highly suggestive of autoimmune encephalitis. Because plasmapheresis was unavailable at the treating institution, the patient had to be transferred to a tertiary facility on day thirty-four for plasma exchange, a therapy that filters pathogenic antibodies from the blood.
The turning point came after four sessions of plasmapheresis. Seizure frequency declined progressively, and neurological responsiveness and awareness gradually returned. Before the transfer, the boy had already begun breathing spontaneously through a surgical tracheostomy placed on day sixteen, after repeated failed attempts to liberate him from the ventilator. Following plasma exchange, he was successfully decannulated, weaned from nasogastric feeding to a full oral diet as swallowing recovered, and enrolled in intensive multidisciplinary rehabilitation that rebuilt his mobility, muscle strength, and functional independence. After thirty-two days in intensive care and ninety-eight days in hospital, he went home on four oral antiseizure medications: sodium valproate, phenytoin, levetiracetam, and lacosamide.
At one-month follow-up, the results were remarkable. His Glasgow Coma Scale score was a perfect fifteen, and his modified Rankin Scale score of three indicated moderate disability but functional independence. He walked without assistance, ate normally, communicated near his premorbid baseline, and had suffered no further episodes of status epilepticus. Outpatient EEG showed frequent right frontal epileptiform discharges with occasional generalized spike-and-wave activity on a preserved symmetrical background, but no electrographic seizures, consistent with resolution of the acute ictal storm and persistence of a discrete right frontal epileptogenic focus that can be managed chronically.
What makes the case scientifically important is how badly conventional prognostic tools misjudged it. The Status Epilepticus Severity Score, at three out of six, and the END-IT score, at five, both predicted higher mortality and poor functional outcome. The patient also accumulated nearly every risk factor for death identified in large observational studies: generalized convulsive status epilepticus, failure of anesthetic tapering, prolonged seizure duration, multiple anesthetic agents, and cardiovascular instability. Yet the authors argue that these models should complement rather than replace clinical judgment, particularly in young patients with potentially reversible etiologies. Younger age is independently associated with better outcomes, with mortality concentrated in patients over seventy-five, and autoimmune encephalitis carries demonstrably better long-term prognosis than acute brain injuries such as stroke, anoxia, or infection, which drive the worst mortality in super-refractory status epilepticus.
The recovery also depended on painstaking critical care. Prolonged deep sedation and mechanical ventilation routinely generate their own lethal complications, and this patient collected nearly all of them: ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae requiring culture-guided antimicrobial escalation, severe cachexia demanding enteral nutrition, intensive-care-acquired weakness, and a tracheostomy for prolonged airway protection. Throughout, the clinical team held regular multidisciplinary family meetings, counseling relatives repeatedly about a guarded prognosis and the high likelihood of death or severe disability. Aggressive care continued anyway, justified by the patient’s youth and the suspicion of a reversible autoimmune cause. That persistence, the authors suggest, was as decisive as any single drug.
The broader message is aimed squarely at therapeutic nihilism. Prolonged super-refractory status epilepticus should not automatically be written off as futile, even in resource-limited settings where continuous EEG, antibody panels, and plasmapheresis are absent and diagnosis arrives late. Meaningful neurological recovery remains possible despite weeks of seizures, devastating complications, and delayed access to advanced therapies, provided clinicians keep hunting for reversible causes and sustain aggressive multidisciplinary management. For a sixteen-year-old who beat fifty-percent mortality odds, walked out of hospital after ninety-eight days, and now lives independently, the lesson is not statistical. It is human: in the right patient, persistence can outrun the prognosis.
Subject of Research: Favorable neurological recovery after prolonged super-refractory status epilepticus due to suspected autoimmune encephalitis
Article Title: Favorable Neurological Outcome Following Prolonged Super‐Refractory Status Epilepticus in a Resource‐Limited Setting: A Case Report
Article References: Favorable Neurological Outcome Following Prolonged Super‐Refractory Status Epilepticus in a Resource‐Limited Setting: A Case Report. (n.d.). https://doi.org/10.1002/ccr3.73544
Image Credits: AI Generated
DOI: 10.1002/ccr3.73544
Keywords: super-refractory status epilepticus, autoimmune encephalitis, status epilepticus, plasma exchange, intensive care, electroencephalography, immunotherapy, prognostic scores, modified Rankin Scale, resource-limited settings, case report, neurocritical care
Cite Scienmag News
APA MLA Chicago
Ophelia Keating. (September 26, 2026). Teenager Walks Out of Hospital After Weeks of Untreatable Seizures Defying the Odds. Scienmag. https://scienmag.com/teenager-walks-out-of-hospital-after-weeks-of-untreatable-seizures-defying-the-odds/
Ophelia Keating. “Teenager Walks Out of Hospital After Weeks of Untreatable Seizures Defying the Odds.” Scienmag, 26 September 2026, https://scienmag.com/teenager-walks-out-of-hospital-after-weeks-of-untreatable-seizures-defying-the-odds/. Accessed 26 September 2026.
Ophelia Keating. “Teenager Walks Out of Hospital After Weeks of Untreatable Seizures Defying the Odds.” Scienmag. September 26, 2026. https://scienmag.com/teenager-walks-out-of-hospital-after-weeks-of-untreatable-seizures-defying-the-odds/
Copy citation Download RIS
Tags: autoimmune encephalitiscase reportcase study of successful seizure treatmentchallenges in treating super-refractory seizureselectroencephalographyhospital survival despite severe seizuresImmunotherapyintensive careintensive care for status epilepticuslong-term outcomes of status epilepticusmodified Rankin Scaleneurocritical careneurological emergency recoveryneurological resilience in young patientspediatric epilepsy prognosisplasma exchangeprognostic scoresprolonged seizure treatmentrare neurological emergenciesresource-limited settingsseizure management in adolescentsstatus epilepticussuper-refractory status epilepticusteenager with super-refractory status epilepticus
